Multimodal AI Model for GIST Diagnosis Completes Validation — Implications for Preoperative Risk Stratification

References

1. 1.Zhao, Q. (2024). Development and Validation of a Multimodal Artificial Intelligence Model Integrating CT Radiomics, Pathomics, and Clinical Features for the Diagnosis, Risk Stratification, and Genotype Prediction of Gastrointestinal Stromal Tumors. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07454967
2. 2.Joensuu, H., Hohenberger, P., & Corless, C. L. (2013). Gastrointestinal stromal tumour. The Lancet, 382(9896), 973-983. https://doi.org/10.1016/S0140-6736(13)60106-3
3. 3.Casali, P. G., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bielack, S., ... & ESMO Guidelines Committee. (2018). Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 29(Supplement_4), iv68-iv78. https://doi.org/10.1093/annonc/mdy095
4. 4.Vernuccio, F., Taibbi, A., Picone, D., Midiri, M., Lagalla, R., & Bartolotta, T. V. (2020). Imaging of gastrointestinal stromal tumors: From diagnosis to evaluation of therapeutic response. Radiographics, 40(7), 1903-1920. https://doi.org/10.1148/rg.2020190181
5. 5.Nishida, T., Hirota, S., Yanagisawa, A., Sugiyama, T., Nasu, J., Nishimura, J., ... & Tsuji, Y. (2008). Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version. International Journal of Clinical Oncology, 13(5), 416-430. https://doi.org/10.1007/s10147-008-0798-7